Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.

Bradley A, Zheng H, Ziebarth A, Sakati W, Branham-O'Connor M, Blumer JB, Liu Y, Kistner-Griffin E, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Landen CN Jr, Eblen ST.

Carcinogenesis. 2014 May;35(5):1100-9. doi: 10.1093/carcin/bgt489. Epub 2013 Dec 30.

2.

Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.

Ziebarth AJ, Nowsheen S, Steg AD, Shah MM, Katre AA, Dobbin ZC, Han HD, Lopez-Berestein G, Sood AK, Conner M, Yang ES, Landen CN.

Clin Cancer Res. 2013 Jan 1;19(1):170-82. doi: 10.1158/1078-0432.CCR-12-1045. Epub 2012 Nov 12.

3.

Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy.

Ziebarth AJ, Felder MA, Harter J, Connor JP.

Cancer Immunol Immunother. 2012 Jul;61(7):1149-53. doi: 10.1007/s00262-012-1267-8. Epub 2012 May 6.

PMID:
22562378
4.

Smoothened antagonists reverse taxane resistance in ovarian cancer.

Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN.

Mol Cancer Ther. 2012 Jul;11(7):1587-97. doi: 10.1158/1535-7163.MCT-11-1058. Epub 2012 May 2.

5.

Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.

Ziebarth AJ, Smith H, Killian ME, Nguyen NA, Durst JK, Subramaniam A, Kim KH, Leath CA 3rd, Straughn JM Jr, Alvarez RD.

Gynecol Oncol. 2012 Jul;126(1):69-72. doi: 10.1016/j.ygyno.2012.03.046. Epub 2012 Apr 5.

PMID:
22484400
6.

Molecular/genetic therapies in ovarian cancer: future opportunities and challenges.

Ziebarth AJ, Landen CN Jr, Alvarez RD.

Clin Obstet Gynecol. 2012 Mar;55(1):156-72. doi: 10.1097/GRF.0b013e31824b1699. Review.

PMID:
22343235
7.

Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.

Steg AD, Bevis KS, Katre AA, Ziebarth A, Dobbin ZC, Alvarez RD, Zhang K, Conner M, Landen CN.

Clin Cancer Res. 2012 Feb 1;18(3):869-81. doi: 10.1158/1078-0432.CCR-11-2188. Epub 2011 Dec 5.

8.

Hormonal emergency contraception: a clinical primer.

Ziebarth A, Hansen KA.

S D Med. 2007 Mar;60(3):99-101, 103-5. Review. Erratum in: S D Med. 2007 Apr;60(4):157. Dosage error in article text.

PMID:
17455578
9.

Delayed diagnosis of partially obstructed longitudinal vaginal septa.

Ziebarth A, Eyster K, Hansen K.

Fertil Steril. 2007 Mar;87(3):697.e17-20. Epub 2006 Nov 29.

PMID:
17140575

Supplemental Content

Loading ...
Support Center